TOI
The Oncology Institute, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$5.13
−19.72%Price chart
Jul 31Aug 5Aug 10Aug 13Aug 18Aug 21Aug 26Aug 31
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−26.8x
Market Cap
$512.91M
MomentumView details →
1D Return
−19.72%
YTD Return
+66.01%
RSI (14)
48.5
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−26.8x
Market Cap
$512.91M
RSI (14)
48.5
MomentumView details →
1D Return
−19.72%
YTD Return
+66.01%
SummaryUpdated Jun 1, 2026
The Oncology Institute, Inc. (NASDAQ:TOI) is a community-based oncology company founded in 2007 and headquartered in Cerritos, California. The company went public in June 2020 and has grown to become one of the largest value-based oncology providers in the United States. Operating 67 clinic locations across multiple states, TOI specializes in providing comprehensive cancer care services to adult and senior cancer patients through a network of over 100 specialty-trained physicians and healthcare providers.
Similar companies
Latest newsMore news →
Oncology Institute announced it has rebranded as Starling Oncology.28d agoOncology Institute, Inc. issued warrants exercisable for 10,025,535 shares of its common stock to Deerfield Partners, L.P. and affiliates, with an initial exercise price of $8.567 per share and expiration on August 9, 2027.60d ago